Kevin Crofton joined Creo Medical's board in July 2024 and is an accomplished business leader with over three decades of extensive international experience in the technology industry.
Read moreIvonne has extensive experience in corporate finance, having acted as a corporate finance adviser to UK and international companies for more than 20 years at Cenkos Securities plc (now Cavendish) and previously at Merrill Lynch.
Read moreBrent Boucher joined Creo Medical's board in July 2024 and brings extensive experience in the commercialisation of novel medical devices.
Read moreCraig was a founding angel investor in Creo Medical and became CEO in 2012.
Read moreRichard joined Creo Medical as CFO in July 2016. Prior to joining Creo, Richard was CFO of SPTS Technologies, a UK-based, global manufacturer of semiconductor capital equipment.
Read more